What if the next global health upheaval isn’t a new flu or an unknown virus, but something that has been buzzing along in the background for years literally? As chikungunya infections climb to record ...

The Centers for Disease Control and Prevention (CDC) is warning about the deadly mosquito-borne chikungunya virus, which is ...

Just as new outbreaks of chikungunya threaten to become another epidemic, Bavarian Nordic, maker of a vaccine against the ...

Chikungunya virus disease, a debilitating mosquito-borne (Aedes spp) illness caused by an alphavirus, chikungunya virus, is usually endemic in regions with tropical climates.1 Since the beginning of ...

The World Health Organization has issued an urgent call for action as cases of these mosquito-borne infections continue to ...

Our data show 5.6 billion people now live in regions where Aedes mosquitoes can transmit chikungunya, and 2025 outbreaks in ...

Saint Herblain (France), July, 11 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the European Medicines Agency (EMA) will lift the temporary ...

Additionally, EMA noted that while most serious side effects occurred in older people, IXCHIQ ® is effective at triggering the production of antibodies against the chikungunya virus which may be ...

Current operations chief Renee Gala will succeed Bruce Cozadd at Jazz. Meanwhile, Nuclidium raised about $99 million to ...

At its July meeting, the European Medicines Agency’s pharmacovigilance committee (PRAC) completed its review of French specialty vaccine maker Valneva Ixchiq (chikungunya virus vaccine, a live ...

Valneva (NASDAQ:VALN) said on Friday that the European Medicines Agency (EMA) has lifted the suspension on its chikungunya vaccine, Ixchiq, for adults aged 65 years and older. The EMA's safety ...